Načítá se...
Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo
OBJECTIVE: Carcinosarcoma is a deadly gynecologic malignancy with few effective treatment options. The study of new therapies is difficult because of its rarity. The objective of this study was to determine the efficacy of neratinib in the treatment of HER2 amplified carcinosarcoma. METHODS: The eff...
Uloženo v:
| Vydáno v: | Gynecol Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4587290/ https://ncbi.nlm.nih.gov/pubmed/26260909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2015.08.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|